Skip to main content
Article thumbnail
Location of Repository

Cost-effectiveness and mental health

By Martin Knapp, David McDaid, Silvia Evers, Luis Salvador-Carulla and Vidar Halsteinl


MHEEN II Policy Briefing

Topics: H Social Sciences (General)
Publisher: PSSRU
Year: 2008
OAI identifier:
Provided by: LSE Research Online

Suggested articles


  1. (1986). An evaluation of the effectiveness of suicide prevention centers, doi
  2. (2007). and the MHEEN Group doi
  3. (2008). Antidepressant medications and other treatments of depressive disorders: a technical review of evidence by a Task Force established by the CINP, doi
  4. (1997). Care in the Community: Illusion or Reality?Wiley, doi
  5. (2006). Children with antisocial behaviour: what do they cost and who pays?
  6. (2007). Commissioning, Interpreting and Making Use of Evidence on Mental Health Promotion and Mental Disorder Prevention: An Everyday Primer. Lisbon: Direccao Geral de Saude.
  7. (1999). Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial, doi
  8. (2007). Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive–behavioural therapy in adolescents with major depression, doi
  9. (2000). Cost-utility analysis in depression: the McSad utility measure for depression health states, Psychiatric Services, doi
  10. (2001). Costing psychiatric interventions, in G. Thornicroft (ed) Measuring Mental Health Needs,
  11. (2004). Economic evaluation of suicide prevention programs for young adults in Florida,Business Review Cambridge,
  12. (2005). Economic evaluations of child and adolescent mental health interventions: a systematic review, doi
  13. (2003). Evaluating health interventions: exploiting the potential, doi
  14. (2001). Financial cost of social exclusion: follow up study of antisocial children into adulthood, doi
  15. (1996). Guidelines for authors and peer reviewers of economic submissions to the BMJ: the BMJ Economic Evaluation Working Party, doi
  16. (1995). Hallam A doi
  17. (2003). How can research organisations more effectively transfer research knowledge to decision makers? doi
  18. (2006). Medida de la calidad de vida en el analisis economico de la atencion a la salud mental. [Measuring quality of life in the economic analysis of mental health],
  19. (2000). Modelling in health economics evaluation. What is its place? What is its value? doi
  20. (2005). Novak A doi
  21. (2007). Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis, doi
  22. (2005). Patient-based utilities for bipolar disorder-related health states, doi
  23. (1997). QALYs and mental health care, Social Psychiatry and Cost-effectiveness and mental healthPsychiatric doi
  24. (2007). Resource use and costs associated with patients treated for depression in primary care, doi
  25. (2001). The cost effectiveness of specialised facilities for service users with persistent challenging behaviours, doi
  26. (2002). The EPSILON study – a study of care for people with schizophrenia in five European centres, doi
  27. (2000). The influence of economic evaluation studies on decision making: a European survey, doi
  28. (2004). The public's preference concerning the allocation of financial resources to health care: results from a representative population survey in Germany, doi
  29. (2006). The Use of Economic Evaluations in NHS Decision Making: A Review and Empirical Investigation.
  30. (2007). The Warwick-Edinburgh Mental Well-Being Scale; development and UK validation, doi
  31. (2004). Twelve years on: service use and costs for people with mental health problems who left psychiatric hospital, doi
  32. (2004). Tylee A
  33. (2003). Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study, Acta Psychiatrica Scandinavica, supplement 416, doi
  34. (2007). Unit Costs of Health and Social Care
  35. (2003). Use of pharmacoeconomics information: report doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.